Alx Oncology (ALXO)PRESIDENT & CSO sold ~$17K

~$17K

Approx. value · 11K sh @ $1.58

581K

Holds after · shares reported

Traded

Dec 30, 2024

Filed

Jan 2, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 2, 2024InsiderDirector purchased ~$46K of ALXO shares in the open market
2. Dec 30, 2024 · this disclosureInsiderOfficer sold ~$17K of ALXO shares in the open market

What came next

1. Dec 30, 2024InsiderCFO sold ~$2.3K of ALXO shares in the open market
2. Jan 6, 2025InsiderCFO sold ~$4K of ALXO shares in the open market
3. Feb 19, 2025Insider · 3 peopleInsiders: 3 sales (~$5K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alx Oncology

For Alx Oncology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALXO page.

Other recent filings by Jaume Pons, PRESIDENT & CSO

• SEC Form 4 at Alx Oncology (ALXO)Feb 21, 2025

The full history of Jaume Pons, PRESIDENT & CSO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Alx Oncology

• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Jul 6, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 4Mar 23, 2026
• SEC Form 4Mar 23, 2026

Everything OQRO holds on this company is on its ALXO page.